Page last updated: 2024-08-21

medroxyprogesterone and Precancerous Conditions

medroxyprogesterone has been researched along with Precancerous Conditions in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19907 (77.78)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaino, T; Sager, G; Vereide, AB; Ørbo, A1
Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM1
Kedzia, H; Warenik-Szymankiewicz, A; Wolna, M1
Bonte, J1
Miura, K; Nagasawa, H; Nakajima, K; Namiki, H; Niki, K; Noguchi, Y; Ohta, K1
Aoki, M; Ishida, M; Nagasawa, H; Sakagami, N1
Dallenbach-Hellweg, G1
Fujii, M; Hagiwara, K; Nagasawa, H1
Izutsu, T; Kagabu, T; Kurokawa, Y; Nishiya, I; Satoh, K; Yoshizumi, N1

Reviews

1 review(s) available for medroxyprogesterone and Precancerous Conditions

ArticleYear
[Conservative organ-preserving measures in precancerous stages of endometrial cancer].
    Der Gynakologe, 1988, Volume: 21, Issue:4

    Topics: Adult; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; Uterine Neoplasms

1988

Trials

1 trial(s) available for medroxyprogesterone and Precancerous Conditions

ArticleYear
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Gynecologic oncology, 2005, Volume: 97, Issue:3

    Topics: Administration, Oral; Adult; Aged; Apoptosis; bcl-2-Associated X Protein; Biopsy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Progestins; Proto-Oncogene Proteins c-bcl-2

2005

Other Studies

7 other study(ies) available for medroxyprogesterone and Precancerous Conditions

ArticleYear
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
    Obstetrics and gynecology, 1980, Volume: 55, Issue:6

    Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms

1980
[Conservative treatment of two young women with cancer and precancerous lesions of the endometrium].
    Ginekologia polska, 1994, Volume: 65, Issue:6

    Topics: Adult; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone; Precancerous Conditions; Treatment Outcome

1994
[Beneficial effects of contraceptive doses and large doses of medroxyprogesterone in the prevention and treatment of uterine hyperplasia].
    Gynakologische Rundschau, 1978, Volume: 18, Issue:3-4

    Topics: Adenocarcinoma; Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Uterine Cervical Neoplasms; Uterine Neoplasms

1978
Interrelationship between pituitary and ovarian hormones in normal and neoplastic growth of mammary glands of mice.
    Annals of the New York Academy of Sciences, 1986, Volume: 464

    Topics: Animals; Cell Transformation, Neoplastic; DNA; DNA Replication; Estrogens; Female; Growth Hormone; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Ovary; Precancerous Conditions; Progesterone; Prolactin

1986
Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice.
    Breast cancer research and treatment, 1988, Volume: 12, Issue:1

    Topics: Animals; Cell Transformation, Neoplastic; Endometriosis; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Organ Size; Precancerous Conditions; Uterine Neoplasms

1988
Inhibition by medroxyprogesterone acetate of precancerous mammary hyperplastic alveolar nodule formation in mice.
    Breast cancer research and treatment, 1985, Volume: 5, Issue:1

    Topics: Animals; Antineoplastic Agents; Body Weight; Estrus; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred Strains; Organ Size; Precancerous Conditions; Pregnancy; Prolactin

1985
[Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
    Nihon Sanka Fujinka Gakkai zasshi, 1985, Volume: 37, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; RNA, Neoplasm; Software; Uterine Neoplasms

1985
chemdatabank.com